drugset / Trial / NCT03423732
Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)
Phase 2/3
Unknown
50 enrolled
John Paul II Hospital, Krakow
KCRI · collabNational Center for Research and Development, Poland · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main objective of the CIRCULATE project is to compare the clinical outcomes of CardioCell administration in treatment of ischemic damages of cardiovascular system with control group, who will be treated by the administration of placebo during the sham procedure.
Timeline
- Start
- 2018-04-19
- Primary completion
- 2021-05-31
- Completion
- 2021-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CardioCell | Cell therapy | 3e+07 cells | Other |